pubmed-article:8342798 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C0242402 | lld:lifeskim |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C0373440 | lld:lifeskim |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C0021880 | lld:lifeskim |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C0007818 | lld:lifeskim |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C0022180 | lld:lifeskim |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C0028215 | lld:lifeskim |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C0246631 | lld:lifeskim |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C0234388 | lld:lifeskim |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:8342798 | lifeskim:mentions | umls-concept:C0428714 | lld:lifeskim |
pubmed-article:8342798 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:8342798 | pubmed:dateCreated | 1993-8-30 | lld:pubmed |
pubmed-article:8342798 | pubmed:abstractText | A new short-acting opioid, remifentanil, is metabolized by esterase activity in blood and tissue. It is important to know whether remifentanil may decrease the time to recovery of opioid-induced cardiovascular and cerebral effects compared to that of other short-acting agents such as alfentanil. | lld:pubmed |
pubmed-article:8342798 | pubmed:language | eng | lld:pubmed |
pubmed-article:8342798 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8342798 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:8342798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8342798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8342798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8342798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8342798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8342798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8342798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8342798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8342798 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8342798 | pubmed:month | Jul | lld:pubmed |
pubmed-article:8342798 | pubmed:issn | 0003-3022 | lld:pubmed |
pubmed-article:8342798 | pubmed:author | pubmed-author:AlbrechtR FRF | lld:pubmed |
pubmed-article:8342798 | pubmed:author | pubmed-author:HoffmanW EWE | lld:pubmed |
pubmed-article:8342798 | pubmed:author | pubmed-author:CunninghamFF | lld:pubmed |
pubmed-article:8342798 | pubmed:author | pubmed-author:JamesM KMK | lld:pubmed |
pubmed-article:8342798 | pubmed:author | pubmed-author:BaughmanV LVL | lld:pubmed |
pubmed-article:8342798 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8342798 | pubmed:volume | 79 | lld:pubmed |
pubmed-article:8342798 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8342798 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8342798 | pubmed:pagination | 107-13; discussion 26A | lld:pubmed |
pubmed-article:8342798 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:meshHeading | pubmed-meshheading:8342798-... | lld:pubmed |
pubmed-article:8342798 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:8342798 | pubmed:articleTitle | Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide. | lld:pubmed |
pubmed-article:8342798 | pubmed:affiliation | Anesthesiology Department, University of Illinois, Chicago. | lld:pubmed |
pubmed-article:8342798 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8342798 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8342798 | lld:pubmed |